Barclays’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66B Buy
6,786,107
+2,330,946
+52% +$543M 0.4% 28
2025
Q4
$922M Sell
4,455,161
-1,186,507
-21% -$235M 0.22% 63
2025
Q3
$1.05B Buy
5,641,668
+449,445
+9% +$77M 0.23% 57
2025
Q2
$793M Sell
5,192,223
-215,937
-4% -$33.2M 0.18% 64
2025
Q1
$897M Buy
5,408,160
+770,819
+17% +$121M 0.25% 52
2024
Q4
$671M Sell
4,637,341
-1,085,775
-19% -$168M 0.19% 59
2024
Q3
$927M Buy
5,723,116
+564,681
+11% +$90M 0.25% 48
2024
Q2
$754M Sell
5,158,435
-3,148,867
-38% -$468M 0.23% 59
2024
Q1
$1.31B Sell
8,307,302
-638,239
-7% -$102M 0.46% 28
2023
Q4
$1.4B Sell
8,945,541
-2,341,936
-21% -$359M 0.51% 27
2023
Q3
$1.76B Sell
11,287,477
-288
-0% -$47.5K 1.09% 10
2023
Q2
$1.87B Buy
11,287,765
+4,059,112
+56% +$655M 1.18% 9
2023
Q1
$1.12B Sell
7,228,653
-3,995,221
-36% -$645M 0.51% 19
2022
Q4
$1.98B Buy
11,223,874
+4,344,809
+63% +$750M 0.89% 12
2022
Q3
$1.12B Buy
6,879,065
+2,064,530
+43% +$349M 1.23% 9
2022
Q2
$855M Sell
4,814,535
-1,731,717
-26% -$309M 0.52% 27
2022
Q1
$1.16B Sell
6,546,252
-2,620,967
-29% -$446M 0.91% 13
2021
Q4
$1.57B Sell
9,167,219
-827,471
-8% -$135M 0.58% 26
2021
Q3
$1.61B Buy
9,994,690
+3,456,063
+53% +$590M 0.73% 20
2021
Q2
$1.08B Buy
6,538,627
+1,486,048
+29% +$246M 0.51% 23
2021
Q1
$830M Buy
5,052,579
+754,468
+18% +$122M 0.45% 26
2020
Q4
$676M Buy
4,298,111
+623,434
+17% +$92M 0.36% 38
2020
Q3
$547M Buy
3,674,677
+628,135
+21% +$92.9M 0.32% 45
2020
Q2
$428M Sell
3,046,542
-407,082
-12% -$59.3M 0.33% 42
2020
Q1
$453M Sell
3,453,624
-1,901,265
-36% -$270M 0.36% 46
2019
Q4
$781M Sell
5,354,889
-1,316,832
-20% -$179M 0.43% 30
2019
Q3
$863M Buy
6,671,721
+524,418
+9% +$69.1M 0.54% 22
2019
Q2
$856M Buy
6,147,303
+1,049,887
+21% +$145M 0.52% 24
2019
Q1
$713M Buy
5,097,416
+548,493
+12% +$73.5M 0.49% 24
2018
Q4
$587M Buy
4,548,923
+568,792
+14% +$79.3M 0.45% 27
2018
Q3
$550M Buy
3,980,131
+54,343
+1% +$7.22M 0.38% 29
2018
Q2
$476M Sell
3,925,788
-946,389
-19% -$118M 0.41% 30
2018
Q1
$624M Buy
4,872,177
+95,272
+2% +$12.9M 0.48% 25
2017
Q4
$667M Buy
4,776,905
+2,162,028
+83% +$301M 0.54% 23
2017
Q3
$340M Sell
2,614,877
-264,021
-9% -$35M 0.35% 33
2017
Q2
$381M Sell
2,878,898
-295,789
-9% -$37.7M 0.41% 29
2017
Q1
$395M Buy
3,174,687
+455,112
+17% +$54.4M 0.43% 28
2016
Q4
$313M Sell
2,719,575
-579,885
-18% -$67M 0.34% 33
2016
Q3
$390M Buy
3,299,460
+787,406
+31% +$95.5M 0.43% 30
2016
Q2
$305M Sell
2,512,054
-477,480
-16% -$54.3M 0.4% 29
2016
Q1
$323M Sell
2,989,534
-652,246
-18% -$67.5M 0.49% 29
2015
Q4
$371M Sell
3,641,780
-235,531
-6% -$23.7M 0.45% 31
2015
Q3
$361M Sell
3,877,311
-2,901,989
-43% -$281M 0.43% 22
2015
Q2
$658M Buy
6,779,300
+2,094,332
+45% +$210M 0.74% 12
2015
Q1
$469M Sell
4,684,968
-40,713
-0.9% -$4.14M 0.54% 15
2014
Q4
$491M Buy
4,725,681
+615,527
+15% +$64.9M 0.47% 21
2014
Q3
$436M Buy
4,110,154
+219,050
+6% +$22.7M 0.42% 29
2014
Q2
$405M Sell
3,891,104
-1,430,623
-27% -$145M 0.43% 24
2014
Q1
$522M Buy
5,321,727
+437,579
+9% +$40.6M 0.59% 19
2013
Q4
$444M Buy
4,884,148
+349,077
+8% +$32.2M 0.46% 19
2013
Q3
$390M Buy
4,535,071
+666,616
+17% +$59.8M 0.47% 18
2013
Q2
$332M Buy
+3,868,455
New +$328M 0.41% 25

Other funds holding JNJ

Barclays's JNJ Position: Q1 2026 in Review

Barclays increased its Johnson & Johnson (JNJ) stake by 52% in Q1 2026, buying an estimated $543M and bringing the position to 6,786,107 shares worth $1.66B. The position accounts for 0.4% of the portfolio, ranked #28.

Barclays first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.98B in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Barclays held 6,786,107 shares of Johnson & Johnson worth $1.66B as of Q1 2026.
  • Barclays bought 2,330,946 Johnson & Johnson shares in Q1 2026, an estimated $543M.
  • Johnson & Johnson made up 0.4% of Barclays's portfolio in Q1 2026, its #28 holding.
  • Barclays first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Johnson & Johnson position peaked at $1.98B in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.